Sean P. Gates, Oct 15, 2013
Standard-essential patents (“SEPs”) have been at the heart of a debate about the reach of U.S. antitrust law. In recent years, the focus has been on whether breach of a good faith commitment to license on reasonable and non-discriminatory (“RAND”) terms can be the basis for a monopolization claim. The question is whether, in the absence of any fraud or deception at the time of the RAND commitment, an antitrust violation occurs when a
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 18.117.107.90
Please verify email or join us to access premium content!